GRUNENTHAL GMBH

In News

Sun Pharma, Grünenthal Are Said to Vie for US-Listed Organon - Bloomberg.com

Bloomberg.com - Apr 15, 2026

Grünenthal’s proprietary NaV 1.8 inhibitor enters clinical development | news aktuell GmbH - Via TT

Via TT - Feb 18, 2026

Chemotherapy-Induced Peripheral Neuropathy Market to Witness Significant Growth at a CAGR of 14.2% During the Forecast Period (2026-2036) as Novel Therapies Enter Late-Stage Development | DelveInsight - PR Newswire

PR Newswire - Jun 16, 2026

AstraZeneca licenses Zurampic to Grünenthal GmbH in Europe and Latin America - AstraZeneca

AstraZeneca - Jun 02, 2016

Watkins Advises Grünenthal on €500 Million Bond - Latham & Watkins LLP

Latham & Watkins LLP - Dec 02, 2024

Grünenthal's transformation: CEO Gabriel Baertschi about what's ahead for the global leader in pain management - Fierce Pharma

Fierce Pharma - Apr 12, 2021

Four ways Grünenthal spreads misleading claims about opioids around the world - The Examination

The Examination - Jul 29, 2025

Grünenthal: driving innovative treatments in pain and beyond through collaboration and partnerships - Nature

Nature - Sep 01, 2020

Federal Circuit Addresses Obviousness of Polymorphs in Grunenthal GmbH v. Alkem Labs. Ltd., No. 2017-1153 (Fed. Cir. Mar. 28, 2019) - JD Supra

JD Supra - Apr 05, 2019

Polymorph Patent Not Invalid as Obvious - Jones Day

Jones Day - Jul 25, 2019

Putting customers at the center of their go-to-market strategy - kpmg.com

kpmg.com - Jan 19, 2024

AstraZeneca Divests Two Drugs to Grünenthal in $90 Million Deal - BioSpace

BioSpace - Oct 30, 2018

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment